Women's health information
covering breast cancer, infertility,
female sexuality, aging, diet and
women's health policy.
BACK TO...

Aphrodite's Home Page

ARTICLES ABOUT...

Female Sexuality

Relationships

Sexual Dysfunction

Looking Good

STDs

Men

Contraception

Reproductive Health

Conceiving

Pregnancy

Incontinence

Mental Health

Children's Health

Eating Well

Healthy Living

Supplements

Menopause

Weight Issues

Breast Cancer

Custom Search




HELP WITH...

Relationship Questions

Your Dreams

Personal Development

Counseling By Email

DISCUSSION FORUMS...

Female Sexuality

Trying To Conceive

Surviving Miscarriage

Overcoming Infertility

Reproductive Health

General Health

Contraception

Pregnancy

Parenting

Babies and Toddlers

Relationships

Weddings

Separation and Divorce

Mental Health

Diet & Weight

30 November 2007
Concerns Over Consumer Genetic Tests

Direct-to-consumer advertising for commercial genetic testing is on the rise and may be problematic, according to a doctor from Massachusetts General Hospital (MGH). In Obstetrics & Gynecology, MGH's Erin Tracy warns that such testing is poorly regulated and may present potential pitfalls for patients and physicians.

"Some of the tests that are being offered have no proven clinical validity whatsoever and are quite costly," says Tracy. "So patients spend money trying to identify a particular gene to figure out if their child is prone to addictive behavior, for example. If the test comes back positive, parents are often not adequately counseled as to what those results might mean, whether these tests have any proven value, or what resources are available for follow up."

Tracy noted that the majority of DNA tests are "home brews" that are unregulated by the FDA. While the FDA needs more funding to regulate genetic testing, it also is limited in its ability to regulate services based in other countries. According to a 2002 study in Genetics in Medicine, 24 of 105 web sites offering genetic testing directed potential clients to international mailing addresses.

"Some patients with no risk factors for breast cancer come in and request the test for BRCA-1 and BRCA-2 mutations," says Tracy, referring to a recent advertising campaign. "The ads are compelling and they're emotionally driven. I end up spending time discussing why a particular test being advertised is not appropriate when I should be addressing important issues such as eating a healthy diet or smoking cessation." At the same time, she notes, without proper counseling a patient who does not have the BRCA-1 or BRCA-2 mutations might assume she has no risk for breast cancer and forgo recommended mammograms and clinical breast examinations.

"Before any test is ordered, there should be a thought process about whether that particular test is appropriate and what we'll do with it. And physicians need to stay current about what's out there so we can best advise our patients," Tracy concluded.

Related articles:
New Hereditary Breast Cancer Gene Identified
Booby Babble And Breast Cancer Research
Genetic Screening Recommended For Some

Source: Massachusetts General Hospital


Home Page     Q & A     Discussion Forums     About Us     Privacy
Your use of this website indicates your agreement to our terms of use.
© 2002 - 2012 Aphrodite Women's Health and its licensors. All rights reserved.